Hypoxia-activated 2-nitroimidazole-brusatol carbonate prodrugs for enhanced gastric cancer therapy with reduced systemic toxicity

Bioorganic & Medicinal Chemistry · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles